| Ticker Details |
Laboratory Corporation of America Holdings
Laboratory Corp of America Holdings is a healthcare diagnostics company. It is engaged in providing comprehensive clinical laboratory and end-to-end drug development services. It operates in two segments: LabCorp Diagnostics and Covance Drug Development.
|
| IPO Date: |
May 9, 1995 |
| Sector: |
Healthcare |
| Industry: |
Health Care Providers and Services |
| Market Cap: |
$21.31B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.51 | 0.90%
|
| Avg Daily Range (30 D): |
$3.05 | 1.16%
|
| Avg Daily Range (90 D): |
$3.12 | 1.16%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.79M |
| Avg Daily Volume (30 D): |
.51M |
| Avg Daily Volume (90 D): |
.52M |
| Trade Size |
| Avg Trade Size (Sh.): |
89 |
| Avg Trade Size (Sh.) (30 D): |
23 |
| Avg Trade Size (Sh.) (90 D): |
24 |
| Institutional Trades |
| Total Institutional Trades: |
19,548 |
| Avg Institutional Trade: |
$5.37M |
| Avg Institutional Trade (30 D): |
$22.96M |
| Avg Institutional Trade (90 D): |
$23.19M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$13.27M |
| Avg Closing Trade (30 D): |
$38.34M |
| Avg Closing Trade (90 D): |
$37.51M |
| Avg Closing Volume: |
73.28K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$11.36
|
$3.37
|
$2
|
|
Diluted EPS
|
$11.29
|
$3.35
|
$1.98
|
|
Revenue
|
$14.14B
|
$3.54B
|
$3.52B
|
|
Gross Profit
|
$4.08B
|
$1.01B
|
$993.2M
|
|
Net Income / Loss
|
$942.7M
|
$278M
|
$164.9M
|
|
Operating Income / Loss
|
$1.44B
|
$380.8M
|
$267.6M
|
|
Cost of Revenue
|
$10.07B
|
$2.52B
|
$2.52B
|
|
Net Cash Flow
|
$620.7M
|
$449.9M
|
$-42M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jul 03, 2023
|
1164:1000
|
|
May 13, 2002
|
2:1
|
|
Jun 12, 2001
|
2:1
|
|
May 04, 2000
|
1:10
|
|
|
|
